Cell technology in the treatment of male infertility caused by nonobstructive azoospermia


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article is devoted to new methods for treating male infertility caused by nonobstructive azoospermia using different cells technologies: spermatogenic stem cells (SSC), mesenchymal stem cells (MSCs), platelets rich plasma (PRP), Stromal Vascular Fraction (SVF) as well as the creation of «artificial sperm» from somatic cells. In recent years, increased interest in these methods because of their high efficiency at a high level of security. At the same time, efficacy and safety of these technologieshas not yet been clinically studied from the perspective of evidence- based medicine.

Full Text

Restricted Access

About the authors

M. V Epifanova

Research Institute of Uronephrology and Human Reproductive Health Department of Urology

Email: epifanova_maya@mail.ru
Ph.D., Leading Researcher

M. E Chalyi

Sechenov First Moscow State Medical University (Sechenov University)

Email: chalyy@bk.ru
Dr.Med.Sci., Prof. at the Department of Urology

N. O Pereverzina

Sechenov First Moscow State Medical University (Sechenov University)

Email: natalia.pereverzina@gmail.com
Fifth Year Student, Directorate of Educational Programs of the International School of Personalized and Translational Medicine

S. A Artemenko

Sechenov First Moscow State Medical University (Sechenov University)

Email: sergey.artemenko.94@mail.ru
Fifth Year Student, Directorate of Educational Programs of the International School of Personalized and Translational Medicine

References

  1. Nieschlag E., Behre H.M. Andrology (eds), Male reproductive health and dysfunction, 2nd Ed. Springer Verlag, Berlin, 2010. Chapter 5. Р. 83-87.
  2. Snick H.K., Snick T.S., Evers J.L., Collins J.A. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod 1997;12(7):1582-1588.
  3. WHO Manual for the Standardised Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press, 2000. 353 p.
  4. Halder A., Kumar P., Jain M., Kalsi A.K. Genomics: Tool to predict and prevent male infertility. Front Biosci (Schol Ed). 2017;9:448-508.
  5. WHO Laboratory Manual for the Exam of Human Semen and Spermcervical Mucus Interaction. 4th- edn. Cambridge: Cambridge University Press, 1999. 450 p.
  6. Zhebentyaev A.A. Male infertility. Vestnik VGMU. 2008;7(2). Russian (Жебентяев А.А. Мужское бесплодие. Вестник ВГМУ. 2008;7(2).
  7. Su L.M., Palermo G.D., Goldstein M. et al. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia: testicular histology can predict success of sperm retrieval. J Urol. 1999;161:112-116.
  8. Carpi A., Sabanegh E., Mechanick J. Controversies in the management of nonobstructive azoospermia. Fertil Steril. 2009;91:963-970.
  9. Cocuzza M., Alvarenga C., Pagani R. The epidemiology and etiology of azoospermia. Clinics (Sao Paulo). 2013;68(Suppl. 1):15-26.
  10. Schlegel P.N. et al. Testiculat sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia. Urology. 1997;49:435-440.
  11. Sadri-Ardekani H., Atala A. Testicular tissue cryopreservation and spermatogonial stem cell transplantation to restore fertility: from bench to bedside, Stem Cell Res. Ther. 2014;5:68.
  12. Brinster R.L., Zimmermann J.W. Spermatogenesis following male germ-cell transplantation. Proc. Natl. Acad. Sci. U. S. A. 1994;91:11298-11302.
  13. Hayashi K., Ohta H. et al. Reconstitution ofthe mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011;146:519-532.
  14. Nayernia К., Nolte J. et al. In vitro-differentiated embryonic stem cells give rise to gem male gametes that can generate offspring mice. Dev. Cell.
  15. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
  16. West F., Mumaw J. et al. Human haploid cells differentiated from meiotic competent clonal germ cell lines that originated from embryonic stem cells. Stem Cells Dev. 2011;20:1079-1088.
  17. Kanatsu-Shinohara M., Inoue K., Ogonuki N., Morimoto H., Ogura A., Shinohara T., Serum- and feeder-free culture of mouse germline stem cells. Biol. Reprod. 2011;84:97-105.
  18. Wu Z., Falciatori I., Molyneux L.A., Richardson T.E., Chapman. K.M., Hamra F.K. Spermatogonial culture medium: an effective and afficient nutrient mixture for culturing rat spermatogonial stem cells. Biol. Reprod. 2009;81:77-86.
  19. Sadri-Ardekani H., Akho М.А., van der Veen F., Repping S., van Pelt A.M.M. In vitro propagation of human prepubertal spermatogonial stem cells. JAMA. 2001;305:2416-2418.
  20. Ghasemzadeh-Hasankolaei M., Eslaminejad M.B., Sedighi-Gilani M. Derivation of male germ cells from ram bone marrow mesenchymal stem cells by three different methods and evaluation of their fate after transplantation into the testis. In Vitro Cell Dev Biol Anim. 2016; 52(1):49-61.
  21. Mehrabani D. at al. Adipose tissue-derived mesenchymal stem cells repair germinal cells of seminiferous tubules of busulfan-induced azoospermic rats. J. Hum Reprod Sci. 2015;8(2):103-110.
  22. Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management ofAzoospermia. Khaled Abdulmoneim Gadalla, Man Clinic for Andrology, Male Infertility and Sexual Dysfunction ClinicalTrials.gov Identifier: NCT02008799
  23. СаЫй C., Bugrukcu B. et al. Recovery of fertility in azoospermin rats after injection of adipose-tissue-derived mesenchymal stem cells: the sperm generation. Biomed Res Int. 2013;2013:529589.
  24. Murohara T., Shintani S., Kondo K. Autologous adipose-derived regenerative cells for therapeutic angiogenesis. Curr Pharm Des. 2009; 15(24):2784-2790.
  25. Kondo K., Shintani S., Shibata R., Murakami H., Murakami R., Imaizumi M., Kitagawa Y., Murohara T. Implantatiom ofadipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29(1): 61-66.
  26. Глыбочко П.В., Аляев Ю.Г., Чалый М.Е., Епифанова М.В., Краснов А.О. Применение клеточных технологий в андрологической практике. Урология. 2016;1(прил. 1):44-46
  27. Глыбочко П.В., Чалый М.Е., Епифанова М.В., Еремин И.И., Пулин А.А. Способ лечения эректильной дисфункции. Патент на изобретение РФ № 2622757. Москва. 19 июня 2017. Бюллетень № 17 от 19.06.2017
  28. Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction. Identifier: NCT02472431.
  29. Чалый М.Е., Григорян В.А., Епифанова М.В., Краснов А.О. Эффективность интракавернозного введения аутоплазмы, обогащенной тромбоцитами, в лечении эректильной дисфункции. Урология. 2015;4:76-79
  30. Епифанова М.В. Применение аутоплазмы, обогащенной тромбоцитарными факторами роста, в лечении эректильной дисфункции. Дисс. канд. мед. наук. М., 2016. 167 с.
  31. Marx R.E. et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998;85:638-646.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies